FOB Price
Get Latest Price|
- Minimum Order
Country:
Others1
Model No:
CAA-OC-459
FOB Price:
Place of Origin:
-
Price for Minimum Order:
-
Minimum Order Quantity:
-
Packaging Detail:
-
Delivery Time:
-
Supplying Ability:
-
Payment Type:
-
Product Group :
-
Prodcut name | Daclatasvir Dihydrochloride |
Standard packing material | Aluminum foil bag inside, then waterproof bag or carton |
Appearance | White powder |
Purity | *9% |
Storage | Preserve in tight,light-resistant containers in a cool place |
Daclatasvir Dihydrochloride , DAKLINZA. The form of dihydrochloride is used clinically. Bristol-Myers Squibb's new hepatitis C drug daclatasvir Dihydrochloride is the first potent NS5A replication complex inhibitor approved by the European Union and Japan. It is mainly used in combination with other drugs for all 1, 2Chemicalbook, 3, and 4 genotypes of chronic C Treatment of adult infected with hepatitis B (HCV). In addition, the safety of daclatasvir Dihydrochloride in the treatment of hepatitis C has been proven across various groups, including elderly patients, groups with advanced liver disease, recipient groups after liver transplantation, and HIV/HCV co-infected groups.
Daclatasvir Dihydrochloride
Country: | Others1 |
Model No: | CAA-OC-459 |
FOB Price: | Get Latest Price |
Place of Origin: | - |
Price for Minimum Order: | - |
Minimum Order Quantity: | - |
Packaging Detail: | - |
Delivery Time: | - |
Supplying Ability: | - |
Payment Type: | - |
Product Group : | - |